Cholestasis
Elayna O. Rubens
<p>Elayna Rubens, MD, is Co-Director, Intraoperative Neurophysiologic Monitoring Service at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. Rubens’s primary clinical focus is performing intraoperative neurophysiologic monitoring to enhance the safety of surgeries that may affect the brain, spinal cord or peripheral nerves.</p><p>After obtaining her Bachelor of Science in biology and neurobiology from Cornell University in 1998, Dr. Rubens earned her Doctor of Medicine at Albert Einstein College of Medicine in 2003. Dr. Rubens completed her neurology residency at Beth Israel Deaconess Medical Center in 2007, where she was Chief Resident in her final year. She went on to complete a clinical neurophysiology fellowship at NewYork-Presbyterian-Weill Cornell Medical Center in 2009.</p><p>Dr. Rubens’s research focuses on enhancing neurophysiologic monitoring techniques to improve the safety of surgeries involving the nervous system. Her research also involves using clinical evoked potential testing and electroencephalography to improve neurologic patient care, particularly in the critical care setting. She has shared her work through numerous peer-reviewed publications and invited presentations.</p><p>Dr. Rubens is board certified by the American Board of Psychiatry and Neurology. She is a Fellow of the American Clinical Neurophysiology Society and member of the American Epilepsy Society and the American Academy of Neurology.</p>
Orna Rosen
Evelyn M. Rondinel
Yolanda Rivas
Dr. Rivas graduated from the University of Carabobo School of Medicine in Valencia, Venezuela, where she also spent her internship. After serving as a surgery assistant at Guerra Mendez Medical Center in Valencia, Dr. Rivas completed her Pediatric Residency at SUNY Health Science Center in Brooklyn and her Pediatric Gastroenterology and Nutrition Fellowship at Children?s Hospital at Montefiore. She directs the Pediatric Gastroenterology and Nutrition Fellowship Program at The Children's Hospital at Montefiore.
John F. Reinus
<FONT color=#000000>Clinical practice limited to liver diseases. Research on liver diseases and related topics.</FONT>
<p> </p>
<ol>
<li>Gaglio P, Moss N, McGaw C, Reinus JF. Direct-acting antiviral therapy for hepatitis C: Attitudes regarding future use. Dig Dis Sci. 2011; 56:1509-1515.</li>
<li>Flattau A, Olaywi M, Gaglio PJ, Marcus P, Meissner P, L Dorfman EB, Reinus JF. Social barriers to listing for adult liver transplantation: Their prevalence and association with program characteristics. Liver Transpl. 2011; 17:1167-1175.</li>
<li>Golowa YS, Cynamon J, Reinus JF, Kinkhabwala M, Abrams M, Jagust M, Chernyak V, Kaubisch A. Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads. J Vasc Interv Radiol. 2012; 23:1031-1035.</li>
<li>Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis. 2012; 16:659-666. Review.</li>
<li>Kinkhabwala M, Lindower J, Reinus JF, Principe AL, Gaglio PJ. Expedited liver allocation in the United States: a critical analysis. Liver Transpl. 2013; 19: 1159-1165.</li>
<li>Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther. 2014; 39:209-216.</li>
<li>Izzy M, Jibara G, Aljanabi A, Alani M, Giannattasio E, Zaidi H, Said Z, Gaglio P, Wolkoff A, Reinus JF. Limited fibrosis progression but significant mortality in patients ineligible for interferon-based hepatitis C therapy. J Clin Exp Hepatol. 2016 Jun;6(2):100-8.</li>
<li>Chacko KR, Reinus J. Spectrum of alcoholic liver disease. Clin Liver Dis. 2016 Aug;20(3):419-27.</li>
<li>Chacko KR, Reinus J. Extrahepatic complications of nonalcoholic fatty liver disease. Clin Liver Dis. 2016 May;20(2):387-401. Review.</li>
</ol>
<p> </p>
<p>John F. Reinus, MD, is Emeritus Medical Director, Liver Transplantation and Professor, Medicine at Montefiore Einstein. His work centers on liver transplantation, end-stage liver disease and viral hepatitis.</p><p>Dr. Reinus studied Pre-Medical Sciences at Columbia University before earning his Doctor of Medicine at Cornell Medical College in 1981. He then began an internal medicine internship at Bellevue Hospital Center, completing it in 1982. Following this, Dr. Reinus completed a residency in internal medicine at the same institution in 1984 before completing a hepatology fellowship at Emory University School of Medicine in 1985. He went on to complete a fellowship in gastroenterology at the same institution, finishing it in 1987. Dr. Reinus then completed a Transplant Hepatology Preceptorship at the Center for Liver Disease and Transplantation in 2006.</p><p>Building on his clinical focus, Dr. Reinus’ research is focused on liver diseases and related topics. His work has been published in peer-reviewed journals, books, chapters, reviews and abstracts, and he has presented at numerous conferences and meetings.</p><p>Dr. Reinus is board certified by the American Board of Medical Examiners in Internal Medicine, Gastroenterology and Transplant Hepatology. He is a fellow of the American Association for the Study of Liver Diseases and a member of the American Gastroenterological Association and the American Society of Transplantation.</p>
Samuel J. Rednor
Nephrology and Critical Care.
Dr. Rednor’s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation.
<p>Samuel J. Rednor, DO, is Director of Wellness, Critical Care and Assistant Professor, Medicine at Montefiore Einstein. His clinical focus is nephrology and critical care.</p><p>After earning his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine in 2013, Dr. Rednor completed his residency in internal medicine at Southampton Hospital in 2016, where he was Chief Resident for one year. He then completed his renal fellowship at Montefiore in 2018, where he was Chief Renal Fellow during his last year. Dr. Rednor went on to complete an additional fellowship at Montefiore in critical care, which he completed in 2019.</p><p>Dr. Rednor’s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation. His work has been published in peer-reviewed journals and he has given multiple lectures and presentations.</p><p>Dr. Rednor is board certified in Internal Medicine, Nephrology and Critical Care Medicine by the American Osteopathic Board of Internal Medicine. He is a member of the American Society of Nephrology (ASN), the American Osteopathic Association (AOA), the Society of Critical Care Medicine (SCCM) and the American College of Chest Physicians (CHEST). In 2018, Dr. Rednor won the Sharon R. Silbiger Teaching Award for excellence in teaching and in recognition as Outstanding Fellow of the Year from Einstein.</p>
Debra H. Pan
<!--Dr. Pan graduated from Soochow University School of Medicine in China, and completed her Pediatric Residency at Long Island College Hospital, and her Pediatric Gastroenterology and Nutrition Fellowship at The Mount Sinai Hospital in New York City. She specializes in viral hepatitis, inflammatory bowel disease, acid reflux, celiac disease, tube feeding, nutrition and endoscopies.--><p>Debra H. Pan, MD, MS, is an Attending Physician in the Division of Gastroenterology, Hepatology, and Nutrition at Children's Hospital at Montefiore (CHAM) and an Associate Professor of Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is on pediatric gastrointestinal and liver conditions such as inflammatory bowel disease, acid reflux, Helicobacter pylori gastritis, tube feeding, endoscopy, cholestasis, viral hepatitis, autoimmune hepatitis, and liver transplant. </p><p>A graduate from Soochow University School of Medicine in China in 1983, Dr. Pan received her Master of Science in Cardiac Electrophysiology from the same institute in 1989. From 1991 to 2000, she completed a postdoctoral research fellowship in Pharmacology and Toxicology at Michigan State University for 2 years and then continued gastrointestinal research at Columbia University. She completed her Pediatric residency at Long Island College Hospital in 2003, and her Pediatric Gastroenterology and Nutrition fellowship at Mount Sinai Hospital in New York City in 2005.</p><p>Dr. Pan's recent research focuses on the treatment outcomes of Helicobacter pylori infection and the natural history of the hepatitis B virus infection. Her work has been published in numerous peer-reviewed journals, books and review articles, and she is also an active journal reviewer for multiple journals.</p><p>Dr. Pan is a member of leading professional societies including North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), and the American Association for the Study of Liver Diseases. She is board certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Gastroenterology and Nutrition.</p>